Age-related Macular Degeneration - Causes, Treatment & When to See a Doctor

```html

What is Age‑Related Macular Degeneration?

Age‑related macular degeneration (AMD) is a progressive eye disease that damages the macula – the central part of the retina responsible for sharp, straight‑ahead vision needed for reading, driving, recognizing faces, and fine detail work. AMD does not cause total blindness but can severely impair central vision while peripheral vision usually remains intact.

There are two main forms:

• Dry (atrophic) AMD: Characterized by a gradual thinning and loss of retinal pigment cells. It accounts for about 80‑90 % of cases.
• Wet (neovascular or exudative) AMD: Involves the growth of abnormal blood vessels under the retina that leak fluid or blood, leading to rapid vision loss.

According to the CDC and the Mayo Clinic, AMD is the leading cause of irreversible vision loss in people over age 60 in industrialized countries.

Common Causes

AMD is multifactorial. While age is the strongest risk factor, several other conditions and lifestyle factors increase the likelihood of developing the disease.

• Genetic predisposition: Variants in the CFH and ARMS2 genes raise risk.
• Smoking: Increases odds by 2–3 times (CDC).
• High blood pressure (hypertension): Damages retinal blood vessels.
• Cardiovascular disease: Atherosclerosis reduces blood flow to the retina.
• Obesity and high‑fat diet: Linked to increased oxidative stress in retinal cells.
• Excess sunlight exposure: Ultraviolet (UV) and blue light can accelerate retinal damage.
• Age‑related lens changes (cataract surgery): May alter ocular environment, slightly raising AMD risk.
• Chronic inflammation: Systemic inflammatory disorders (e.g., rheumatoid arthritis) have been associated with AMD.
• Low intake of antioxidants (vitamins C, E, lutein, zeaxanthin): Deficiency reduces retinal protection.
• Family history of AMD: First‑degree relatives have a 3‑ to 5‑fold higher risk.

Associated Symptoms

Symptoms differ between dry and wet AMD and may develop slowly over months to years.

• Blurred or distorted central vision (straight lines may appear wavy – “metamorphopsia”).
• Dark or empty spot in the middle of the visual field.
• Difficulty reading small print or recognizing faces.
• Need for brighter lighting when performing close‑up tasks.
• Reduced color saturation, especially for reds and greens.
• In wet AMD: sudden onset of visual distortion, rapid central vision loss, or seeing spots/floaters.

When to See a Doctor

Prompt evaluation can preserve vision, especially for wet AMD, which progresses quickly.

• Any new or worsening central visual blurring.
• Seeing straight lines that appear bent or “wiggly.”
• Development of a dark spot in the center of your sight.
• Rapid change in vision over days or weeks.
• Difficulty performing normal activities such as reading, using a smartphone, or driving.

If you notice any of these changes, schedule an eye exam within 24‑48 hours. Early treatment of wet AMD can prevent significant vision loss.

Diagnosis

An ophthalmologist (or optometrist with retinal referral) uses several tests to confirm AMD and determine its stage.

1. Comprehensive dilated eye exam: Allows direct visualization of the macula and detection of drusen (yellow deposits) or pigment changes.
2. Optical coherence tomography (OCT): Non‑invasive imaging that creates cross‑sectional pictures of retinal layers, identifying fluid, thickening, or atrophy.
3. Fluorescein angiography (FA) or Indocyanine Green Angiography (ICG): Dye is injected to highlight abnormal blood vessels in wet AMD.
4. Amsler grid test: Simple home‑based tool to detect distortion; patients may be asked to perform it regularly.
5. Fundus photography: Captures detailed images for baseline comparison over time.
6. Genetic testing (optional): May help assess risk in patients with strong family history.

These investigations help differentiate dry from wet AMD and guide treatment planning.

Treatment Options

Treatment varies by AMD type, stage, and individual health.

Dry (Atrophic) AMD

• AREDS2 nutritional supplement: A specific formula of vitamins C, E, zinc, copper, lutein (10 mg) and zeaxanthin (2 mg) shown to slow progression in intermediate AMD (Mayo Clinic).
• Lifestyle modifications: Smoking cessation, blood pressure control, weight management, and a diet rich in leafy greens, fish, and nuts.
• Low‑vision aids: Magnifiers, high‑contrast reading glasses, and electronic devices to maximize remaining vision.

Wet (Neovascular) AMD

• Anti‑VEGF intravitreal injections: Medications such as ranibizumab (Lucentis), aflibercept (Eylea), and brolucizumab (Beovu) inhibit vascular endothelial growth factor, reducing leakage and often improving vision. Typically administered every 4‑8 weeks.
• Photodynamic therapy (PDT): Verteporfin‑mediated laser treatment for select cases.
• Laser photocoagulation: Direct laser to seal abnormal vessels (used less frequently due to risk of retinal damage).
• Combination therapy: Anti‑VEGF plus PDT can be effective for stubborn lesions.

Home & Supportive Care

• Regular use of prescribed supplements.
• Protect eyes from excessive sunlight with UV‑blocking sunglasses (400 nm protection).
• Maintain a healthy diet: leafy greens (spinach, kale), colorful vegetables, fatty fish (salmon, sardines), and nuts.
• Engage in regular physical activity to improve cardiovascular health.
• Enroll in a low‑vision rehabilitation program for adaptive strategies.

Prevention Tips

While age cannot be altered, many modifiable factors can lower the risk or delay progression.

• Don’t smoke: If you smoke, seek cessation resources immediately.
• Control blood pressure and cholesterol: Follow your physician’s regimen.
• Adopt a Mediterranean‑style diet: Emphasize fruits, vegetables, whole grains, olive oil, and fish.
• Take AREDS2‑approved supplements if you have intermediate AMD: Do not self‑prescribe high‑dose vitamins without guidance.
• Wear sunglasses with 100 % UV and blue‑light protection: Reduces cumulative light‑induced retinal damage.
• Regular eye examinations: At least once every 1–2 years after age 60, or more often if you have risk factors.
• Exercise regularly: At least 150 minutes of moderate aerobic activity each week.
• Manage weight: Aim for a BMI < 25 kg/m².
• Monitor vision at home: Use an Amsler grid monthly and note any changes.

Emergency Warning Signs

If any of the following occur, seek immediate ophthalmologic or emergency care:

• Sudden, severe loss of central vision in one eye.
• Rapid appearance of black spots, flashing lights, or a “curtain” over part of your visual field.
• Acute distortion of straight lines within days.
• New onset of numerous floaters combined with blurred vision.

These symptoms often signal the transition to wet AMD, where early anti‑VEGF therapy can preserve vision.

Key Takeaways

Age‑related macular degeneration is a leading cause of vision loss in older adults, but early detection and appropriate treatment can maintain functional sight. Understanding risk factors, staying vigilant for visual changes, and following evidence‑based lifestyle and medical interventions are essential steps for anyone at risk.

For personalized advice, always consult an eye‑care professional. The information above reflects current guidance from reputable sources such as the Mayo Clinic, CDC, NIH, and the World Health Organization.

```